Vanderbilt-Ingram Cancer Center

Cancer fight personal for VICC Ambassadors chair

Read more about Cancer fight personal for VICC Ambassadors chair

As this year’s chair of the VICC Ambassadors, Ashley Larcinese, is driven by her experiences to see that research is funded at VICC.

Imaging Biomarkers of Lymphatic Dysfunction

Read more about Imaging Biomarkers of Lymphatic Dysfunction

Persons with secondary arm and/or upper quadrant lymphedema following cancer therapies commonly are prescribed complete decongestive therapy as a course of management of their lymphedema. The investigators will perform a repeated-measures cross-over trial to test the hypothesis that mobilization of protein enriched hardened tissue using graded negative pressure therapy in conjunction with complete decongestive therapy (CDT) is more effective to standard CDT alone for secondary lymphedema management.

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Read more about Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.

Annual Pumpkin Patch helps cancer research funds grow

Read more about Annual Pumpkin Patch helps cancer research funds grow

The annual Pumpkin Patch, which runs this year until Oct. 31, in Franklin, Tennessee, is a fundraising effort by the Cooper Trooper Foundation. Profits from the fundraiser support a pediatric cancer research fund and other efforts set up with Monroe Carell Jr.

Combination therapy improves small-cell lung cancer survival

Read more about Combination therapy improves small-cell lung cancer survival

Patients who received atezolizumab in addition to standard chemotherapy lived two months longer than those treated with chemotherapy alone, according to a recent study published in the New England Journal of Medicine.

Predators’ gift bolsters fight against pediatric cancer

Read more about Predators’ gift bolsters fight against pediatric cancer

Nashville Predators goaltender Pekka Rinne, Predators executives and executives from Tri Star Energy (Twice Daily) made their annual presentation recently of proceeds from the team’s 365 Pediatric Cancer Fund to Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Mary Kay Foundation grant to bolster immunotherapy research

Read more about Mary Kay Foundation grant to bolster immunotherapy research

Charles Caskey, Ph.D., has received a cancer research grant from The Mary Kay Foundation to study how focused ultrasound therapy could be an ideal helper for immunotherapy.

Eric Skaar, Ph.D., M.P.H.

Ernest W. Goodpasture Professor of Pathology
Vice Chair for Basic Research, Department of Pathology, Microbiology and Immunology
Director, Vanderbilt Institute for Infection, Immunology, and Inflammation
Director, Division of Molecular Pathogenesis

Contact

Phone

(615) 496-4272

eric.skaar@vumc.org

Department of Pathology, Microbiology and Immunology
Medical Center North, Room A-5102
1161 21st Avenue South
Nashville, TN 37232

Eric Skaar, Ph.D., M.P.H.

Ernest W. Goodpasture Professor of Pathology
Vice Chair for Basic Research, Department of Pathology, Microbiology and Immunology
Director, Vanderbilt Institute for Infection, Immunology, and Inflammation
Director, Division of Molecular Pathogenesis

(615) 496-4272

eric.skaar@vumc.org

Department of Pathology, Microbiology and Immunology
Medical Center North, Room A-5102
1161 21st Avenue South
Nashville, TN 37232